(Q37969921)

26 August 2017

Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy (English)

1 reference

26 August 2017

0 references

1 reference

Paolo Pozzilli

1

0 references

publication date

20 December 2011

1 reference

Nature Reviews Endocrinology

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

2

1 reference

26 August 2017

78-80

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2011.228

26 August 2017

0 references

cites work

Adenoviral overexpression of the glutamylcysteine ligase catalytic subunit protects pancreatic islets against oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Age-corrected beta cell mass following onset of type 1 diabetes mellitus correlates with plasma C-peptide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Response of human islets to isolation stress and the effect of antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.228

31 March 2020

Identifiers

DOI

10.1038/NRENDO.2011.228

1 reference

26 August 2017

1 reference

PubMed ID

22183128